Search Results - "Cantarovich, M."

Global Transplantation COVID Report March 2020 by Ahn, C., Amer, H., Anglicheau, D., Ascher, N.L., Baan, C.C., Battsetset, G., Bat-Ireedui, B., Berney, T., Betjes, M.G.H., Bichu, S., Birn, H., Brennan, D., Bromberg, J., Caillard, S., Cannon, R.M., Cantarovich, M., Chan, A., Chen, Z.S., Chapman, J.R., Cole, E.H., Cross, N., Durand, F., Egawa, H., Emond, J.C., Farrero, M., Friend, P.J., Geissler, E.K., Ha, J., Haberal, M.A., Henderson, M.L., Hesselink, D.A., Humar, A., Jassem, W., Jeong, J.C., Kaplan, B., Kee, T., Kim, S.J., Kumar, D., Legendre, C.M., Man, K., Moulin, B., Muller, E., Munkhbat, R., Od-Erdene, L., Perrin, P., Rela, M., Tanabe, K., Tedesco Silva, H., Tinckam, K.T., Tullius, S.G., Wong, G.

Get full text

Outcomes of Recipients With Pancreas Transplant Alone Who Develop End-Stage Renal Disease by Singh, S.K., Kim, S.J., Smail, N., Schiff, J., Paraskevas, S., Cantarovich, M.

“…Recipients of pancreas transplant alone (PTA) may be at increased risk for developing end-stage renal disease (ESRD). The survival experience of PTA recipients…”
Get full text

The Outcome of Heart Transplant Recipients Following the Development of End‐Stage Renal Disease: Analysis of the Canadian Organ Replacement Register (CORR) by Alam, A., Badovinac, K., Ivis, F., Trpeski, L., Cantarovich, M.

“…End‐stage renal disease is a significant complication of heart transplantation (HTx), but our understanding of dialysis outcomes in HTx recipients remains…”
Get full text

The PROMISE Study: A Phase 2b Multicenter Study of Voclosporin (ISA247) Versus Tacrolimus in De Novo Kidney Transplantation by Busque, S., Cantarovich, M., Mulgaonkar, S., Gaston, R., Gaber, A. O., Mayo, P. R., Ling, S., Huizinga, R. B., Meier‐Kriesche, H‐U.

“…Voclosporin (VCS, ISA247) is a novel calcineurin inhibitor being developed for organ transplantation. PROMISE was a 6‐month, multicenter, randomized,…”
Get full text

The Clinical Impact of an Early Decline in Kidney Function in Patients Following Heart Transplantation by Cantarovich, M., Hirsh, A., Alam, A., Giannetti, N., Cecere, R., Carroll, P., Edwardes, M. E.

“…Renal dysfunction is a well‐known complication following heart transplantation. We examined an early decline in kidney function as a predictor of progression…”
Get full text

Canadian Cardiovascular Society Consensus Conference update on cardiac transplantation 2008: Executive Summary by Haddad, H., MD, Isaac, D., MD, Legare, J.F., MD, Pflugfelder, P., MD, Hendry, P., MD, Chan, M., MD, Cantin, B., MD, Giannetti, N., MD, Zieroth, S., MD, White, M., MD, Warnica, W., MD, Doucette, K., MD, Rao, V., MD, Dipchand, A., MD, Cantarovich, M., MD, Kostuk, W., MD, Cecere, R., MD, Charbonneau, Eric, MD, Ross, H., MD, Poirier, N., MD

Get full text

First global forum on education on organ donation and transplantation for schools by Cantarovich, M., Birk, P., Ekbeg, H., Delmonico, F., Schoenberg, R., Garcia, C., Manyalich, M., Wall, W., Arbogast, H., Sherry, W., Young-Kipp, S., Cantarovich, F.

“…Cantarovich M, Birk P, Ekbeg H, Delmonico F, Schoenberg R, Garcia C, Manyalich M, Wall W, Arbogast H, Sherry W, Young‐Kipp S, Cantarovich F. First global forum…”
Get full text

Delayed Graft Function Has an Equally Bad Impact on Deceased Donor Renal Graft Survival in Both Standard Criteria Donors and Expanded Criteria Donors by Hassanain, M, Tchervenkov, J, Cantarovich, M, Metrakos, P, Paraskevas, S, Keith, D, Baran, D, Fernandez, M, Mangel, R, Chaudhury, P

“…Abstract Introduction The use of expanded criteria donors (ECDs) is still limited because of inferior graft survival compared to standard criteria donors…”
Get full text

RECOVERY OF GRAFT FUNCTION EARLY POST TRANSPLANT DETERMINES LONG-TERM GRAFT SURVIVAL IN DECEASED DONOR (DD) RENAL TRANSPLANTS: 1072 by Tchervenkov, J, Cantarovich, M, Paraskevas, S, Metrakos, P, Baran, D, Hussanaian, M, Fernandez, M

Get full text

490: Prolonged Immunosuppression with Anti-CD25 Monoclonal Antibodies in Long-Term Heart Transplant Patients by Cantarovich, M, Giannetti, N, Routy, J.-P, Cecere, R, Barkun, J

Get full text

Long-term calcineurin inhibitor "holiday" using daclizumab in a heart transplant patient with acute renal dysfunction by Potter, B, Giannetti, N, Cecere, R, Cantarovich, M

Get more information

Recovery of Graft Function Early Posttransplant Determines Long-Term Graft Survival in Deceased Donor Renal Transplants by Hassanain, M, Tchervenkov, J.I, Cantarovich, M, Metrakos, P, Paraskevas, S, Keith, D, Baran, D, Fernandez, M, Mangel, R, Chaudhury, P

“…Abstract Introduction Because kidneys show remarkable resilience and can recover function, we examined the impact on long-term graft survival in deceased donor…”
Get full text

Prolonged lymphopenia following anti-thymocyte globulin induction is associated with decreased long-term graft survival in liver transplant recipients by Vrochides, D, Hassanain, M, Metrakos, P, Tchervenkov, J, Barkun, J, Chaudhury, P, Cantarovich, M, Paraskevas, S

“…Induction with anti-thymocyte globulin (ATG) during solid organ transplantation is associated with an improved clinical course and leads to prolonged…”
Get full text

Re-vascularization may not increase graft survival after hepatic artery thrombosis in liver transplant recipients by Vrochides, D, Hassanain, M, Metrakos, P, Barkun, J, Paraskevas, S, Chaudhury, P, Cantarovich, M, Tchervenkov, J

“…Hepatic artery thrombosis (HAT) occurs in 3% to 11% of all liver transplantations. Some authors have reported good outcomes with early thrombectomy. To…”
Get full text

The impact of thymoglobulin on renal function and calcineurin inhibitor initiation in recipients of orthotopic liver transplant: A retrospective analysis of 298 consecutive patients by TCHERVENKOV, J. I, TZIMAS, G. N, CANTAROVICH, M, BARKUN, J. S, METRAKOS, P

“…Renal dysfunction remains the Achilles' heel of calcineurin inhibitor (CI)use. The purpose of this study was to assess our institutional, renal-sparing…”
Get full text

History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion by Cantarovich, M, Barkun, J, Giannetti, N, Cecere, R, Besner, J-G, Tchervenkov, J

“…Therapeutic drug monitoring of CsA has evolved since the introduction of CsA microemulsion. The purpose of the present review is to summarize the history of…”
Get full text

474: Assessing safety and efficacy of Neoral®/everolimus maintenance therapy in cardiac transplant recipients: 12 month data by Ross, H, Burton, J, Pflugfelder, P, Cantarovich, M, Ignaszewski, A, Howlett, J, White, M, Haddad, H, Dorent, R, Sips, C, Vaillancourt, M

Get full text

Best single time points as surrogates to the tacrolimus andmycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation by Mardigyan, Vartan, Tchervenkov, Jean, Metrakos, Peter, Barkun, Jeffrey, Deschenes, Marc, Cantarovich, Marcelo

“…Tacrolimus and mycophenolate mofetil (MMF) are immunosuppressive agents used for the prevention of allograft rejection in liver transplant recipients…”
Get full text

Do biliary endoprostheses decrease biliary complications after liver transplantation? by Barkun, J.S, Tzimas, G.N, Cantarovich, M, Metrakos, P.P, Deschênes, M, Alpert, E, Paraskevas, S, Tchervenkov, J.I

“…Most technical complications after orthotopic liver transplantation (OLT) are related to the biliary tree. This report reviews the role of routine…”
Get full text

Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction by Cantarovich, M, Quantz, M, Elstein, E, Ergina, P, Magnan, C, de Varennes, B

Get full text